Abeona Therapeutics Inc.

NasdaqCM:ABEO Stock Report

Market Cap: US$326.0m

Abeona Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ABEO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Jun 26SellUS$103,695Christine Berni-SilversteinIndividual18,160US$5.71
09 Jun 26SellUS$301,921Vishwas SeshadriIndividual56,344US$5.43
09 Jun 26SellUS$59,646Brendan O’MalleyIndividual11,131US$5.43
09 Jun 26SellUS$51,549Madhav VasanthavadaIndividual9,620US$5.43
09 Jun 26SellUS$126,954Joseph VazzanoIndividual23,692US$5.43
22 May 26SellUS$35,463Mark AlvinoIndividual6,500US$5.46
11 May 26SellUS$33,073Madhav VasanthavadaIndividual5,548US$5.96
16 Mar 26SellUS$3,737Joseph VazzanoIndividual785US$4.76
02 Feb 26SellUS$10,181Mark AlvinoIndividual2,000US$5.09
02 Feb 26SellUS$91,962Leila AllandIndividual18,065US$5.09
02 Feb 26SellUS$82,895Eric CrombezIndividual16,284US$5.09
02 Feb 26SellUS$75,412Donald WuchterlIndividual14,814US$5.09
02 Feb 26SellUS$102,168Christine Berni-SilversteinIndividual20,070US$5.09
22 Jan 26SellUS$372,267Vishwas SeshadriIndividual69,832US$5.33
22 Jan 26SellUS$99,507Joseph VazzanoIndividual18,666US$5.33
22 Jan 26SellUS$72,383Brendan O’MalleyIndividual13,578US$5.33
22 Jan 26SellUS$66,658Madhav VasanthavadaIndividual12,610US$5.29
21 Jan 26SellUS$70,574Mark AlvinoIndividual13,500US$5.23
13 Nov 25SellUS$71,168Mark AlvinoIndividual15,000US$4.74
29 Sep 25SellUS$48,730Joseph VazzanoIndividual9,035US$5.39
29 Sep 25SellUS$103,954Vishwas SeshadriIndividual19,274US$5.39
29 Sep 25SellUS$50,516Brendan O’MalleyIndividual9,366US$5.39
22 Sep 25SellUS$3,736Brendan O’MalleyIndividual688US$5.43
15 Aug 25SellUS$110,358Joseph VazzanoIndividual15,000US$7.36
14 Aug 25SellUS$32,683Eric CrombezIndividual4,718US$6.93
22 Jul 25SellUS$9,975Joseph VazzanoIndividual1,502US$6.64
09 Jul 25SellUS$62,879Faith CharlesIndividual10,738US$5.86
09 Jul 25SellUS$102,053Brendan O’MalleyIndividual17,428US$5.86
09 Jul 25SellUS$148,799Joseph VazzanoIndividual25,411US$5.86
09 Jul 25SellUS$76,669Christine Berni-SilversteinIndividual13,093US$5.86
09 Jul 25SellUS$406,503Vishwas SeshadriIndividual69,420US$5.86
09 Jul 25SellUS$76,669Mark AlvinoIndividual13,093US$5.86

Insider Trading Volume

Insider Buying: ABEO insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ABEO?
Owner TypeNumber of SharesOwnership Percentage
General Public8,492,43014.9%
Individual Insiders9,387,13616.5%
Hedge Funds11,120,38119.5%
Institutions27,995,19749.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 68.2% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.8%
Nantahala Capital Management, LLC
5,013,052US$28.7m1.01%4.3%
5.61%
BlackRock, Inc.
3,195,530US$18.3m1.13%no data
5.44%
Aigh Capital Management, LLC
3,100,000US$17.7m55%2.79%
5.28%
Cable Car Capital LLC
3,007,329US$17.2m20.3%10.02%
5.16%
Daniel Kaufman
2,943,629US$16.8m0%no data
4.77%
James Russell
2,720,875US$15.6m0%no data
4.7%
Suvretta Capital Management, LLC
2,676,000US$15.3m0%0.61%
3.8%
Vanguard Capital Management, LLC
2,164,851US$12.4m0%no data
2.41%
Vishwas Seshadri
1,374,079US$7.9m-3.94%no data
2.22%
Kennedy Capital Management LLC
1,263,511US$7.2m20.3%0.2%
2.12%
Geode Capital Management, LLC
1,209,797US$6.9m6.39%no data
1.93%
The Goldman Sachs Group, Inc.
1,099,171US$6.3m129%no data
1.68%
State Street Global Advisors, Inc.
957,328US$5.5m6.55%no data
1.68%
Nan Fung Trinity (HK) Limited
956,770US$5.5m0%0.82%
1.46%
Propel Bio Management, LLC
829,557US$4.7m-0.15%12.86%
1.41%
AWM Investment Company Inc
803,130US$4.6m3.75%0.55%
1.35%
683 Capital Management, LLC
770,000US$4.4m0%0.74%
1.31%
Stonepine Capital Management LLC
746,587US$4.3m5.23%4.02%
1.14%
Silverarc Capital Management, LLC
648,942US$3.7m3.38%1.69%
1.12%
J. Goldman & Co., L.P.
640,530US$3.7m60.6%0.22%
1.07%
Diametric Capital, LP
611,520US$3.5m-11.9%1.37%
1.03%
Balyasny Asset Management L.P.
589,847US$3.4m-0.32%0.01%
0.92%
Citigroup Inc.
522,445US$3.0m0.26%no data
0.91%
Joseph Vazzano
518,437US$3.0m-8.69%no data
0.89%
Simplify Asset Management Inc.
507,988US$2.9m1.53%0.05%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/24 08:55
End of Day Share Price 2026/06/24 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Abeona Therapeutics Inc. is covered by 18 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
George ZavoicoB. Riley Securities, Inc.
Kristen KluskaCantor Fitzgerald & Co.